DE2342880A1 - Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung - Google Patents
Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendungInfo
- Publication number
- DE2342880A1 DE2342880A1 DE19732342880 DE2342880A DE2342880A1 DE 2342880 A1 DE2342880 A1 DE 2342880A1 DE 19732342880 DE19732342880 DE 19732342880 DE 2342880 A DE2342880 A DE 2342880A DE 2342880 A1 DE2342880 A1 DE 2342880A1
- Authority
- DE
- Germany
- Prior art keywords
- parts
- methylpiperazino
- methylthio
- found
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7324874A FR2257294B1 (ja) | 1973-07-06 | 1973-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2342880A1 true DE2342880A1 (de) | 1975-01-30 |
Family
ID=9122191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19732342880 Ceased DE2342880A1 (de) | 1973-07-06 | 1973-08-24 | Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5849548B2 (ja) |
BE (1) | BE803803A (ja) |
CH (1) | CH582171A5 (ja) |
DE (1) | DE2342880A1 (ja) |
ES (1) | ES418113A1 (ja) |
FR (1) | FR2257294B1 (ja) |
GB (1) | GB1434544A (ja) |
LU (1) | LU68263A1 (ja) |
MX (1) | MX2978E (ja) |
NO (1) | NO137205C (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2622639A1 (de) * | 1975-05-23 | 1976-12-09 | Marpha Soc | 2,4-diamino-5-brom-6-chlor-pyrimidinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2417507A2 (fr) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides |
JPS54159877A (en) * | 1978-06-07 | 1979-12-18 | Matsushita Electronics Corp | Detection method for semiconductor substrate position and break |
FR2503162A1 (fr) * | 1981-04-07 | 1982-10-08 | Pharmindustrie | Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments |
JPS6177335A (ja) * | 1984-09-25 | 1986-04-19 | Kazumichi Kimura | 半導体ペレツト不良マ−ク検出装置 |
IT1191845B (it) * | 1986-01-20 | 1988-03-23 | Dompe Farmaceutici Spa | Alchiloli derivati farmacologicamente attivi |
JPH02114936U (ja) * | 1989-03-03 | 1990-09-14 |
-
1973
- 1973-07-06 FR FR7324874A patent/FR2257294B1/fr not_active Expired
- 1973-08-16 NO NO3260/73A patent/NO137205C/no unknown
- 1973-08-20 LU LU68263A patent/LU68263A1/xx unknown
- 1973-08-20 BE BE134751A patent/BE803803A/xx not_active IP Right Cessation
- 1973-08-22 ES ES418113A patent/ES418113A1/es not_active Expired
- 1973-08-23 CH CH1213673A patent/CH582171A5/xx not_active IP Right Cessation
- 1973-08-24 DE DE19732342880 patent/DE2342880A1/de not_active Ceased
- 1973-09-06 JP JP48100728A patent/JPS5849548B2/ja not_active Expired
- 1973-09-12 GB GB4286673A patent/GB1434544A/en not_active Expired
- 1973-11-08 MX MX003804U patent/MX2978E/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2622639A1 (de) * | 1975-05-23 | 1976-12-09 | Marpha Soc | 2,4-diamino-5-brom-6-chlor-pyrimidinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel |
Also Published As
Publication number | Publication date |
---|---|
NO137205B (no) | 1977-10-10 |
CH582171A5 (ja) | 1976-11-30 |
JPS5849548B2 (ja) | 1983-11-05 |
FR2257294B1 (ja) | 1977-07-01 |
BE803803A (fr) | 1974-02-20 |
ES418113A1 (es) | 1976-03-16 |
FR2257294A1 (ja) | 1975-08-08 |
LU68263A1 (ja) | 1973-10-24 |
GB1434544A (en) | 1976-05-05 |
JPS5025578A (ja) | 1975-03-18 |
NO326073L (ja) | 1975-02-03 |
MX2978E (es) | 1980-01-17 |
NO137205C (no) | 1978-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3026201C2 (ja) | ||
DE1965264A1 (de) | Pyrazinoylsulfamide und Verfahren zu ihrer Herstellung | |
DE2009408A1 (de) | 5-Pyridyl-2-imidazolone | |
DE68916198T2 (de) | Carbamoyl-2-Pyrrolidinonverbindungen. | |
DE2342880A1 (de) | Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung | |
DD153206A5 (de) | Verfahren zur herstellung neuer substituierter heterozyklischer phenoxyamine | |
EP0100898A1 (de) | Cycloalkylderivate von Benzisoselenazolonen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
DE2807381A1 (de) | Pharmazeutische zusammensetzung mit einem gehalt an einem 1,3,5-triazin- 2,6-dion | |
DE3129718C2 (ja) | ||
DE1816993A1 (de) | Verfahren zur Herstellung von 1-Aoyl- oder 1-Heteroaroyl- oder 1-Benzheteroaroyl-2-methyl-5-alkoxy-(oder 5-aralkoxy)-indolyl-3-essigsaeuren | |
DE1470367A1 (de) | Verfahren zur Herstellung von in 5-Stellung substituierten 5,6-Dihydro-6-oxopyrido[2,3-b][1,4]benzoxazepinen | |
DE3538063A1 (de) | 6-phenethylaminoalkyl-furo-(3,4-c)-pyridinderivate, verfahren zu deren herstellung und diese enthaltende therapeutische zusammensetzungen | |
DE2550163C2 (de) | Neue Derivate des [1,4]Oxathiino[2,3-c]pyrrols, deren Herstellung und diese enthaltende Zusammensetzungen | |
DE2308064C3 (de) | Benzotriazole, ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE2051961A1 (de) | 6 substituierte Indol eckige Klammer auf 1,2 c eckige Klammer zu chinazoline und Verfahren zu deren Herstellung | |
DE2142792A1 (de) | Heterocyclische Verbindungen | |
DE2511599A1 (de) | Pyrroldiazepine und verfahren zu ihrer herstellung | |
DE953800C (de) | Verfahren zur Herstellung neuer Pyridazone | |
DE2053205A1 (de) | Dihydrofurandenvate und Verfahren zu deren Herstellung | |
DE2360329A1 (de) | 1,7-dialkyl-1,2-dihydro-4-hydroxy-1,8naphthyridin-3-carbonsaeurealkylester | |
EP0054672A1 (de) | Lactamverbindungen, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel | |
CH626076A5 (en) | Process for the preparation of 2-substituted 1,4-benzodiazepine derivatives | |
EP0045520B1 (de) | Pyrimido(4,5-d)(2)benzazepine, Verfahren für ihre Herstellung und diese enthaltende Arzneimittel | |
AT240373B (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
DE1795053A1 (de) | Verfahren zur Herstellung von Verbindungen der Benzodiazepinreihe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OGA | New person/name/address of the applicant | ||
OD | Request for examination | ||
8131 | Rejection |